Parc De Salut Mar
Clinical trials sponsored by Parc De Salut Mar, explained in plain language.
-
Zinc trial aims to boost immunity in HIV patients not helped by standard drugs
Disease control Recruiting nowThis study tests whether taking 75 mg of zinc daily can improve immune function in people with HIV whose CD4 counts remain low despite antiretroviral therapy. About 120 participants will be randomly assigned to receive zinc or continue their usual care. The goal is to see if zinc…
Phase: NA • Sponsor: Parc de Salut Mar • Aim: Disease control
Last updated Apr 26, 2026 19:38 UTC
-
New tool to track life after stomach cancer surgery
Knowledge-focused Recruiting nowThis study aims to translate and validate a Korean quality-of-life questionnaire into Spanish for people who have had stomach cancer surgery. Researchers will enroll 505 adults who are at least one month past surgery and have no cancer recurrence. The goal is to create a reliable…
Sponsor: Parc de Salut Mar • Aim: Knowledge-focused
Last updated May 17, 2026 04:34 UTC
-
Massive spanish study aims to predict and prevent suicide relapse
Knowledge-focused Recruiting nowThis study follows about 3,600 people in Spain who have attempted suicide to understand what factors increase the risk of trying again. Researchers will track participants over time, collect blood samples, and use smartphone tools to monitor mood changes. The goal is to find bett…
Sponsor: Parc de Salut Mar • Aim: Knowledge-focused
Last updated May 17, 2026 04:32 UTC
-
Stroke rehab showdown: does more therapy mean better recovery?
Knowledge-focused Recruiting nowThis study follows 213 adults who had a stroke caused by atrial fibrillation and are in inpatient rehab. Researchers want to see if patients with this type of stroke have different recovery needs and if more intense rehab (3-5 sessions daily) leads to better function at six month…
Sponsor: Parc de Salut Mar • Aim: Knowledge-focused
Last updated May 13, 2026 16:03 UTC
-
Can your DNA predict the best eye injection for AMD?
Knowledge-focused Recruiting nowThis study looks at how a person's genes might influence how well two different eye injections (ranibizumab and bevacizumab) work for wet age-related macular degeneration (AMD). About 630 adults aged 50 and older with untreated wet AMD will receive one of the two drugs and be fol…
Phase: PHASE3 • Sponsor: Parc de Salut Mar • Aim: Knowledge-focused
Last updated May 11, 2026 20:47 UTC